NM_000350.3:c.6386+2C>G
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_000350.3(ABCA4):c.6386+2C>G variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.0000062 in 1,614,038 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 1/1 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000350.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152180Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251432Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135890
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461858Hom.: 0 Cov.: 33 AF XY: 0.00000413 AC XY: 3AN XY: 727236
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152180Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74340
ClinVar
Submissions by phenotype
not provided Pathogenic:5Other:1
This sequence change falls in intron 46 of the ABCA4 gene. It does not directly change the encoded amino acid sequence of the ABCA4 protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs61753043, gnomAD 0.0009%). This variant has been observed in individuals with Stargardt disease (PMID: 28118664, 29925512; Invitae). ClinVar contains an entry for this variant (Variation ID: 99456). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
- -
- -
- -
Canonical splice site variant predicted to result in a null allele in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 33214125, 25265374, 32692840, 14517951, 33724725, 28118664, 29925512) -
- -
Severe early-childhood-onset retinal dystrophy Pathogenic:1
- -
Retinitis pigmentosa 19 Pathogenic:1
The heterozygous c.6386+2C>G variant in ABCA4 was identified by our study, in the compound heterozygous state with a pathogenic variant (ClinVar Variation ID: 7888), in an individual with macular degeneration. This individual also carried a pathogenic variant (ClinVar Variation ID: 7888), however the phase of these variants are unknown at this time. The c.6386+2C>G variant in ABCA4 has been previously reported in 5 affected individuals (PMID: 28118664, PMID: 29925512, PMID: 33724725), but has been identified in 0.0015% (1/68034) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs61753043). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar (Variation ID: 99456) and has been interpreted as pathogenic or likely pathogenic by multiple submitters. Of these 5 previously reported affected individuals (PMID: 28118664, PMID: 29925512, PMID: 33724725), two were compound heterozygotes who carried a reported pathogenic variant in trans (PMID: 33724725, PMID: 28118664) and three were reported compound heterozygotes who carried a reported pathogenic or likely pathogenic variant in unknown phase (PMID: 29925512), which increases the likelihood that the c.6386+2C>G variant is pathogenic. Mini-gene assay and RT-PCR analysis performed on HEK-293 cells transfected with the c.6386+2C>G variant show evidence of altered splicing (PMID: 28118664). However, these types of assays may not accurately represent biological function. This variant is located in the 5' splice region. Computational tools predict a splicing impact, though this information is not predictive enough to determine pathogenicity. Loss of function of the ABCA4 gene is an established disease mechanism in autosomal recessive retinitis pigmentosa 19. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive retinitis pigmentosa 19. ACMG/AMP Criteria applied: PVS1, PS3_Supporting, PM2_Supporting, PM3_Strong (Richards 2015). -
Retinal dystrophy Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at